Literature DB >> 2185252

Increased ferritin gene expression is associated with increased ribonucleotide reductase gene expression and the establishment of hydroxyurea resistance in mammalian cells.

G A McClarty1, A K Chan, B K Choy, J A Wright.   

Abstract

In the present study, we show that hydroxyurea-inactivated ribonucleotide reductase protein M2 has a destabilized iron center, which readily releases iron. In addition, evidence is presented which indicates that single or multistep selection for hydroxyurea resistance, in a variety of mammalian cell lines, leads to alterations in the expression of the gene for the iron storage protein, ferritin. In all hydroxyurea-resistant cell lines examined, including human, hamster, rat, and mouse, there was an elevation in ferritin heavy (H)- and/or light (L)-mRNA levels, but no change in the corresponding gene copy number. A detailed analysis of ferritin expression in a hydroxyurea-resistant mouse L cell line showed that when compared to its wild type counterpart, there was an increase in H subunit concentration but no significant change in L subunit levels. The increased H/L subunit ratio was not brought about by specific changes in the rates of ferritin subunit biosynthesis, but rather resulted from changes in the post-translational stability of H subunits relative to L subunits in the resistant cell line compared to its parental wild type. Also, we show that treatment of cells with hydroxyurea results in an increased rate of ferritin biosynthesis in the absence of changes in H- or L-mRNA levels. These results indicate that the development of even low level hydroxyurea resistance in mammalian cells may require alterations in ferritin gene expression, and they show an interesting relationship between the expressions of two highly regulated activities, ribonucleotide reductase and ferritin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2185252

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Post-transcriptional regulation of H-ferritin gene expression in human monocytic THP-1 cells by protein kinase C.

Authors:  J H Pang; C J Wu; L Y Chau
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

2.  The R1 component of mammalian ribonucleotide reductase has malignancy-suppressing activity as demonstrated by gene transfer experiments.

Authors:  H Fan; A Huang; C Villegas; J A Wright
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

Review 3.  Heat shock proteins and infection: interactions of pathogen and host.

Authors:  T R Garbe
Journal:  Experientia       Date:  1992-07-15

4.  Altered iron homeostasis involvement in arsenite-mediated cell transformation.

Authors:  Jing Wu; Jonathan Eckard; Haobin Chen; Max Costa; Krystyna Frenkel; Xi Huang
Journal:  Free Radic Biol Med       Date:  2005-11-08       Impact factor: 7.376

5.  Ribonucleotide reductase R2 component is a novel malignancy determinant that cooperates with activated oncogenes to determine transformation and malignant potential.

Authors:  H Fan; C Villegas; J A Wright
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

6.  Mechanistic studies of semicarbazone triapine targeting human ribonucleotide reductase in vitro and in mammalian cells: tyrosyl radical quenching not involving reactive oxygen species.

Authors:  Yimon Aye; Marcus J C Long; JoAnne Stubbe
Journal:  J Biol Chem       Date:  2012-08-22       Impact factor: 5.157

7.  Increased ferritin gene expression in atherosclerotic lesions.

Authors:  J H Pang; M J Jiang; Y L Chen; F W Wang; D L Wang; S H Chu; L Y Chau
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

8.  Regulation of mammalian ribonucleotide reductase R1 mRNA stability is mediated by a ribonucleotide reductase R1 mRNA 3'-untranslated region cis-trans interaction through a protein kinase C-controlled pathway.

Authors:  F Y Chen; F M Amara; J A Wright
Journal:  Biochem J       Date:  1994-08-15       Impact factor: 3.857

9.  Phase I study of GTI-2040, an antisense to ribonucleotide reductase, in combination with high-dose cytarabine in patients with acute myeloid leukemia.

Authors:  Rebecca B Klisovic; William Blum; Xiaohui Wei; Shujun Liu; Zhongfa Liu; Zhiliang Xie; Tamara Vukosavljevic; Cheryl Kefauver; Lenguyen Huynh; Jiuxia Pang; James A Zwiebel; Steven Devine; John C Byrd; Michael R Grever; Kenneth Chan; Guido Marcucci
Journal:  Clin Cancer Res       Date:  2008-06-15       Impact factor: 12.531

10.  Ribonucleotide reductase inhibition by metal complexes of Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone): a combined experimental and theoretical study.

Authors:  Ana Popović-Bijelić; Christian R Kowol; Maria E S Lind; Jinghui Luo; Fahmi Himo; Eva A Enyedy; Vladimir B Arion; Astrid Gräslund
Journal:  J Inorg Biochem       Date:  2011-07-31       Impact factor: 4.155

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.